Circulation Reports
Limited Impact of High Bleeding Risk Calculation and Peri-Procedural Discussion on Dual-Antiplatelet Therapy Duration and Clinical Outcomes After Percutaneous Coronary Intervention
By Tomoki Hattori, Ruka Yoshida, Mikito Takefuji and 12 others.
Abstract
Background: The Japanese version of the high bleeding risk (J-HBR) criteria identifies patients with HBR undergoing percutaneous coronary intervention (PCI). We evaluated whether routine J-HBR calculation and peri-procedural discussion on dual-antiplatelet therapy (DAPT) duration were associated with changes in DAPT practice and clinical outcomes.
